These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bilateral ovarian metastases from breast carcinoma on FDG PET-CT. Ho L, Quan V, Henderson R. Clin Nucl Med; 2007 Dec; 32(12):935-6. PubMed ID: 18030045 [Abstract] [Full Text] [Related]
5. FDG PET/CT in serous psammocarcinoma of the ovary. Dong A, Wang Y, Zuo C. Clin Nucl Med; 2014 May; 39(5):453-5. PubMed ID: 23510884 [Abstract] [Full Text] [Related]
15. High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer. Zytoon AA, Murakami K, Eid H, El-Gammal M. Acta Radiol; 2013 Apr 01; 54(3):340-8. PubMed ID: 23319725 [Abstract] [Full Text] [Related]
16. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients. Lee DY, Lee CH, Seo MJ, Lee SH, Ryu JS, Lee JJ. Ann Nucl Med; 2014 Oct 01; 28(8):789-95. PubMed ID: 24965850 [Abstract] [Full Text] [Related]
17. Metastatic Malignant Fibrous Histiocytoma in the Stomach: Imaging With 18F-FDG PET/CT. Fang N, Wang YL, Zeng L, Wu ZJ, Cui XJ. Clin Nucl Med; 2016 Feb 01; 41(2):e123-4. PubMed ID: 26053714 [Abstract] [Full Text] [Related]